Organisation paid for research Program year 2019 Source: CMS Open Payments

Valley Central Research Inc.

Neither a doctor nor a teaching hospital

Research payments

$8,744

3 payments

Through program year 2019, Valley Central Research Inc. is reported as receiving $8,744 in research payments, across 3 payments.

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$8,744	3

Breakdown

Who paid Research payments · program year 2019

AstraZeneca Pharmaceuticals LP $8,533 1 payment
AstraZeneca UK Limited $212 2 payments

Studies the money was for Research payments · program year 2019

A Multinational Randomised Double Blind Placebo Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death Myocardial Infarction or Stroke in Patients with Type 2 Diabetes $8,533 1 payment
A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia $212 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.